7 Aug 2020 12:52
7 August 2020
Cello Health plc
("Cello" or the "Company")
Additional Block Listing of Ordinary Shares
Following the Court Hearing held earlier today in connection with the cash acquisition of Cello Health plc by Pharma Value Demonstration Bidco Limited, the Company announces that an application has been made for a block admission for 2,421,000 new ordinary shares of 10p each ("Ordinary Shares") to be admitted to trading on AIM.
These new Ordinary Shares will be issued and allotted pursuant to the exercise of existing options under the Company's Performance Share Plan 2010, the HM Revenue & Customs Approved Company Share Option Plan and its Unapproved Share Option Plan. New Ordinary Shares, when issued, will rank pari passu with the existing Ordinary Shares of the Company.
Admission of the new Ordinary Shares is expected to occur on 10 August 2020.
Enquires
Cello Health | 020 7812 8460 |
Mark Scott, Chief Executive | |
Mark Bentley, Group Finance Director | |
Cenkos Securities | 020 7397 8900 |
Giles Balleny | |
Harry Hargreaves | |
Buchanan | 020 7466 5000 |
Mark Court | |
Jamie Hooper | |
Sophie Wills |